Please check back for updates on speakers, agenda, and registration information.
SDDS 2025: Stanford Drug Discovery Symposium
Welcome to the 2025 Stanford Drug Discovery Symposium. This event has become a cornerstone in the drug discovery community for networking and collaboration. SDDS 2025 offers a unique opportunity for all members of the drug discovery community – including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community – to share ideas and innovations. We anticipate two days of exciting talks and discussions, including the return of our poster session. We look forward to welcoming you to Stanford for SDDS 2025.
— Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
New Venue!
We are excited to announce a new venue for SDDS 2025, located at the Frances C. Arrillaga Alumni Center at Stanford. This new space offers an enhanced attendee experience, with more room for networking, an expanded poster session, and convenient parking. We look forward to a dynamic environment for collaboration and innovation.
Lifetime Achievement Awardee
Jens Holst, MD, DMSc
Professor, Department of Biomedical Sciences and the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Participants
Srini Akkaraju, MD, PhD
Founder & Managing Partner, Samsara BioCapital.
Jay Bradner, MD
Executive Vice President, R&D, and CSO, Amgen
Patrizia Cavazzoni, MD
Director, Center for Drug Evaluation and Resarch Food and Drug Administration
Jane Grogan, PhD
Executive Vice President and Head of Research, Biogen
Stephen Hoge, MD
President,
Moderna
Samarth Kulkarni, PhD
CEO and Chairman of the Board, CRISPR Therapeutics
Lloyd Minor, MD
Carl and Elizabeth Naumann Professorship for the Dean, Stanford School of Medicine
John Reed, MD, PhD
Executive Vice President, Innovation Medicine, R&D, Johnson & Johnson
Marc Tessier-Lavigne, PhD
CEO, Xaira Therapeutics
Carolyn Bertozzi, PhD
Nobel Laureate 2022
Baker Family Director of Stanford ChEM-H
Robert Bradway, MBA
Chairman and CEO, Amgen
Navin Chaddha, MS
Managing Partner, Mayfield
Aida Habtezion, MD
Chief Medical Officer and Head of Worldwide Medical and Security, Pfizer
Thomas Hudson, MD
Versant Ventures
Ashley Magargee, MBA
CEO, Genentech
Andrew Plump, MD, PhD
President of Research and Development, Takeda
Randy Schekman, PhD
Nobel Laureate, 2013; Professor of Molecular and Cell Biology, University of California, Berkeley
George Yancopoulos, MD, PhD
President and Chief Scientific Officer, Regeneron
Robert Blum, MBA
President and CEO,
Cytokinetics
Rob Califf, MD
Commissioner, U.S. Food and Drug Administration
Levi Garraway, MD, PhD
Executive Vice President, Head of Global Product Dev, and CMO, Roche / Genentech
Alexander Hardy, MBA
President and CEO, BioMarin
Karen Knudsen, MBA, PhD
CEO, American Cancer Society & American Cancer Society Cancer Action Network
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research, Food and Drug Administration
Stephen Quake, D.Phil
Head of Science, Chan Zuckerberg Initiative
Thomas Südhof, MD
Nobel Laureate 2013; Avram Goldstein Professor and Prof of Neurosurgery, Stanford University
Lifetime Achievement Awardees
TBD
Event Program & Poster
TBD
FAQs
Foundation Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Media Partners
Organizers
Amanda Chase, PhD
Associate Director of Strategic Research Development
Stanford Cardiovascular Institute
Kuldev Singh, MD
Professor of Ophthalmology
Stanford University School of Medicine
Sanjay Malhotra, PhD
Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU
Joseph Wu, MD, PhD
Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine
Mark Mercola, PhD
Professor of Medicine
Stanford University School of Medicine
Francesca Mae G. Tongco, MS-HCA
Project Coordinator
Stanford Cardiovascular Institute
For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.